Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Insomnia01:27

Insomnia

Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Insufficient Sleep and Sleep Deprivation01:13

Insufficient Sleep and Sleep Deprivation

Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Testosterone abuse in Brazil: a growing public health challenge.

Clinics (Sao Paulo, Brazil)·2026
Same author

Accuracy of breast density assessment using artificial intelligence by convolutional neural network for carriers of UGT1A1 polymorphisms with Gilbert's Syndrome - a pilot study.

Clinics (Sao Paulo, Brazil)·2026
Same author

Beyond survival: reconstructing body image and femininity after breast cancer.

Revista da Associacao Medica Brasileira (1992)·2026
Same author

Online interventions for the treatment of sexual dysfunctions: systematic review and meta-analysis.

The journal of sexual medicine·2026
Same author

Melatonin Enhances Glutathione Peroxidase Activity and Improves Antioxidant Defense in Cryopreserved Ovarian Transplants: A Rat Model Study.

Antioxidants (Basel, Switzerland)·2026
Same author

Effects of vitamin D supplementation combined with resistance exercise on body composition and metabolic variables in older women: a randomized clinical trial.

Clinics (Sao Paulo, Brazil)·2026

Related Experiment Video

Updated: Jun 10, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

Isoflavones decrease insomnia in postmenopause.

Helena Hachul1, Letícia Campos Brandão, Vânia D'Almeida

  • 1Departamento de Psicobiologia, Universidade Federal de São Paulo, São Paulo, Brazil. helenahachul@psicobio.epm.br

Menopause (New York, N.Y.)
|August 24, 2010
PubMed
Summary

Isoflavone treatment significantly improved sleep efficiency and reduced insomnia symptoms in postmenopausal women. This study confirms isoflavones as an effective intervention for menopausal insomnia.

Related Experiment Videos

Last Updated: Jun 10, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

Area of Science:

  • Menopause Research
  • Sleep Medicine
  • Phytohormone Studies

Background:

  • Postmenopausal insomnia is prevalent, often co-occurring with other sleep disturbances.
  • Isoflavones, a type of phytohormone, show potential in alleviating menopausal symptoms.

Purpose of the Study:

  • To evaluate the effects of isoflavone treatment on subjective and objective sleep parameters in postmenopausal women with insomnia.
  • To assess changes in sleep quality and menopausal symptoms during isoflavone therapy.

Main Methods:

  • A controlled, double-blind study involving postmenopausal women with insomnia.
  • Participants received either 80 mg of isoflavones daily or a placebo for 4 months.
  • Sleep was assessed using questionnaires and polysomnography; statistical analyses included t-tests, ANOVA, and Pearson's correlation.

Main Results:

  • The isoflavone group showed a significant increase in sleep efficiency (77.9% to 83.9%) compared to the placebo group (77.6% to 81.2%).
  • Isoflavones reduced the intensity and frequency of hot flashes and decreased insomnia prevalence.
  • Insomnia severity decreased substantially in the isoflavone group (89.5% to 36.9%) versus the placebo group (94.7% to 63.2%).

Conclusions:

  • Isoflavone treatment effectively reduced insomnia symptoms in postmenopausal women.
  • Polysomnographic analysis confirmed improved sleep efficiency, supporting isoflavones as a beneficial intervention.